MR

Manisha Rohilla

Active Director Director DIN 03579383
DIN 03579383 First appointment Nov 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2011
Shareholding value •••• Premium profile

About Manisha Rohilla

Data last updated:

Manisha Rohilla is a Director at Mace Pharma Private Limited (since 2011). The company operates in Pharma. Mace Pharma Private Limited reported revenue of ₹1.29 Cr (FY 2022).

DIN 03579383
Primary Designation Director
Industry Pharma
First Appointment 04 Nov 2011
Oldest Company Age 14 yrs
Largest company Mace Pharma Private Limited · ₹1.29 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mace Pharma Private Limited U24233HR2011PTC044235
Director04 Nov 20112011₹1.29 Cr (FY 2022)Active

Board colleagues of Manisha Rohilla

NameDINCompanyDesignation
Manoj Kumar03578108Mace Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mace Pharma Private Limited
Premium access

Shareholding and investment profile for Manisha Rohilla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manisha Rohilla

Manisha Rohilla currently holds 1 directorship: Mace Pharma Private Limited (Director, since 04 Nov 2011, revenue ₹1.29 Cr (FY 2022)).

Manisha Rohilla was first appointed on 04 Nov 2011 as Director at Mace Pharma Private Limited.

The current boards of Manisha Rohilla's companies include Manoj Kumar (Mace Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available